company-logo

Shanghai Bio-heart Biological Technology Co., Ltd. operates as an interventional cardiovascular device company in the People's Republic of China. The company focuses on the provision of bioresorbable scaffolds (BRS) and renal denervation (RDN) therapies for the treatment of coronary artery diseases and uncontrolled and resistant hypertension. It is developing Bioheart, a BRS system used in percutaneous coronary intervention procedures for the treatment of coronary artery disease; Iberis 2nd, a multi-electrode RDN product candidate; and drug coated balloon, a sirolimus drug-eluting balloon catheter designed for instent restenosis. The company has collaboration agreements with Terumo (China) Investment Co., Ltd. to conduct clinical trials for Iberis 2nd. Shanghai Bio-heart Biological Technology Co., Ltd. was founded in 2014 and is headquartered in Shanghai, the People's Republic of China.

Shanghai Bio-heart Biological Technology Dividend Announcement

Shanghai Bio-heart Biological Technology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Shanghai Bio-heart Biological Technology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Shanghai Bio-heart Biological Technology Dividend History

Shanghai Bio-heart Biological Technology Dividend Yield

Shanghai Bio-heart Biological Technology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Shanghai Bio-heart Biological Technology stock? Use our calculator to estimate your expected dividend yield:

Shanghai Bio-heart Biological Technology Financial Ratios

P/E ratio-3.07
PEG ratio-0.03
P/B ratio0.53
ROE-16.61%
Payout ratio0.00%
Current ratio24.62
Quick ratio24.39
Cash Ratio18.80

Shanghai Bio-heart Biological Technology Dividend FAQ

Does Shanghai Bio-heart Biological Technology stock pay dividends?
Shanghai Bio-heart Biological Technology does not currently pay dividends to its shareholders.
Has Shanghai Bio-heart Biological Technology ever paid a dividend?
No, Shanghai Bio-heart Biological Technology has no a history of paying dividends to its shareholders. Shanghai Bio-heart Biological Technology is not known for its dividend payments.
Why doesn't Shanghai Bio-heart Biological Technology pay dividends?
There are several potential reasons why Shanghai Bio-heart Biological Technology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Shanghai Bio-heart Biological Technology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Shanghai Bio-heart Biological Technology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Shanghai Bio-heart Biological Technology a dividend aristocrat?
Shanghai Bio-heart Biological Technology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Shanghai Bio-heart Biological Technology a dividend king?
Shanghai Bio-heart Biological Technology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Shanghai Bio-heart Biological Technology a dividend stock?
No, Shanghai Bio-heart Biological Technology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Shanghai Bio-heart Biological Technology stocks?
To buy Shanghai Bio-heart Biological Technology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Shanghai Bio-heart Biological Technology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.